Asthma mediators: current views.
Spina
D
D
The Sackler Institute of Pulmonary Pharmacology, Department of Respiratory Medicine and Allergy, GKT School of Medicine, King's College London, UK. domenico.spina@kcl.ac.uk
D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology*; D001993:Bronchodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018925:Chemokines / Q000378:metabolism / Q000494:pharmacology; D016207:Cytokines / Q000378:metabolism / Q000494:pharmacology; D010450:Endopeptidases / Q000378:metabolism; D006133:Growth Substances / Q000378:metabolism / Q000494:pharmacology; D006632:Histamine / Q000378:metabolism*; D006801:Humans; D050356:Lipid Metabolism; D010455:Peptides / Q000378:metabolism
D001993:Bronchodilator Agents; D018925:Chemokines; D016207:Cytokines; D006133:Growth Substances; D010455:Peptides; D006632:Histamine; D010450:Endopeptidases